Question · Q2 2026
Pat McCann inquired about how SelectRx's current scale has impacted its negotiating position in recent PBM discussions compared to prior agreements. He also asked about the Kansas facility's capacity for incremental volume before requiring significant new capital investment.
Answer
President Bob Grant affirmed that SelectRx's scale, with over 100,000 complex members and proven adherence benefits (e.g., 20% reduction in hospital days), provides significant negotiating leverage and fosters deeper partnerships, leading to a successful PBM negotiation. Regarding the Kansas facility, Bob Grant stated it has very high capacity due to automation and efficient machinery, allowing for substantial customer volume with less staff, and new technology initiatives are being trialed to further enhance efficiency without immediate significant capital investment.
Ask follow-up questions
Fintool can predict
SLQT's earnings beat/miss a week before the call

